English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

presented at: EC E 2 0 1 6 1 .Meier, C.A., et al., Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab, 1994. 78(1): p. 188-96. 2. Vitale, G., et al., Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration. J Clin Endocrinol Metab, 2003. 88(3): p. 1319-22. 3. Over, R., et al., Age modifies the response to recombinant human thyrotropin. Thyroid, 2010. 20(12): p. 1377-84. 4. Hautzel, H., et al., Impact of renal function and demographic/anthropomorphic variables on peak thyrotropin after recombinant human thyrotropin stimulation: a stepwise forward multiple-regression analysis. Thyroid, 2013. 23(6): p. 662-70. Seo Young Sohn1, Eun Kyung Lee2, You Jin Lee2, Yul Hwangbo2, Hae Jin Jun2,Dae Yoon Park2, Ji Hyun Kim2 and Junsun Ryu2

Usefulness of Day 5 sampling in thyroid cancer patients for radioactive iodine therapy with recombinant human thyrotropin